LENA NICKELL: Open Payments
NPI 1033440375 · FRANKFORT, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 34 payments from 9 companies in 2025. Trend: 2023 $515 · 2024 $321 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 17 | $162 |
| AstraZeneca Pharmaceuticals LP | 5 | $78 |
| Axsome Therapeutics, Inc. | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| ABBVIE INC. | 3 | $42 |
| Edwards Lifesciences Corporation | 1 | $41 |
| Lilly USA, LLC | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, Auvelity, CAPLYTA, SAPIEN 3 Ultra RESILIA, JARDIANCE, QULIPTA, XIFAXAN.
Industry payments across KY — which companies pay providers there.
